Skip to main content
    O

    Oramed Pharmaceuticals Inc (ORMP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.90
    +0.19 (+5.12%)

    Market Cap: $161.33M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Oramed Pharmaceuticals Inc (ORMP) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Oramed Pharmaceuticals are Eledon Pharmaceuticals (ELDN), Pyxis Oncology (PYXS) and NeOnc Technologies Holdings, Inc. Common Stock (NTHI). By market cap, Oramed Pharmaceuticals ranks 8th of the 13 companies on this page; Rocket Pharmaceuticals (RCKT) is the largest at $256.82M.

    Peer Comparison

    ORMP's revenue growth of -100.0% is below the peer median of 0.0%. It yields 6.41%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Oramed Pharmaceuticals (ORMP)$161.33M4.3xN/A0.0%N/A-100.0%6.41%
    Eledon Pharmaceuticals Inc (ELDN)$178.63MN/AN/A0.0%N/A0.0%0.00%
    Pyxis Oncology Inc (PYXS)$188.98MN/A11.6x0.0%N/A0.0%0.00%
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)$141.66MN/AN/A0.0%N/A-100.0%0.00%
    OUTLOOK THERAPEUTICS INC (OTLK)$100.54MN/AN/A0.0%-776.9%-99.4%0.00%
    Vanda Pharmaceuticals Inc (VNDA)$241.27MN/A1.0x-119.9%-84.7%24.1%0.00%
    PolyPid (PYPD)$132.25MN/AN/A0.0%N/A0.0%0.00%
    Rocket Pharmaceuticals Inc (RCKT)$256.82MN/AN/A0.0%-2.3%0.0%0.00%
    Invivyd Inc. (IVVD)$171.58MN/A2.9x-183.9%N/A21.2%0.00%
    Protara Therapeutics Inc (TARA)$155.77MN/AN/A0.0%N/A0.0%0.00%
    Sol Gel Technologies Ltd (SLGL)$180.46MN/A125.4x0.0%N/A-96.6%0.00%
    Immunic Inc (IMUX)$102.61MN/AN/A0.0%N/A0.0%0.00%
    Atrium Therapeutics, Inc. Common Stock (RNA)$162.00MN/A3.3x-180.9%-44.5%24.2%0.00%
    Peer median$166.79MN/A3.3x0.0%-64.6%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Oramed Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Eledon Pharmaceuticals Inc (ELDN)
    Eledon Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing drugs for patients living with autoimmune diseases...
    ELDN competitors
    Pyxis Oncology Inc (PYXS)
    Pyxis Oncology, Inc., a preclinical biotechnology company, is dedicated to developing antibody-drug conjugate (ADC) and monoclonal antibody (mAb)...
    PYXS competitors
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)
    NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy...
    NTHI competitors
    OUTLOOK THERAPEUTICS INC (OTLK)
    Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic...
    OTLK competitors
    Vanda Pharmaceuticals Inc (VNDA)
    Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs.
    VNDA competitors
    PolyPid (PYPD)
    PolyPid Ltd., an advanced stage biopharmaceutical company, develops, manufactures and markets products based on the Polymer Lipid Encapsulation Matrix (PLEX)...
    PYPD competitors
    Rocket Pharmaceuticals Inc (RCKT)
    Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases.
    RCKT competitors
    Invivyd Inc. (IVVD)
    Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery...
    IVVD competitors
    Protara Therapeutics Inc (TARA)
    Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to identifying and promoting transformative therapies for the treatment...
    TARA competitors
    Sol Gel Technologies Ltd (SLGL)
    Sol-Gel Technologies Ltd., a specialty clinical-stage pharmaceutical company, is focused on developing and commercializing topical dermatological...
    SLGL competitors
    Immunic Inc (IMUX)
    Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune...
    IMUX competitors
    Atrium Therapeutics, Inc. Common Stock (RNA)
    Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies.
    RNA competitors

    Frequently Asked Questions About ORMP

    Who are Oramed Pharmaceuticals' main competitors?

    The companies most similar to Oramed Pharmaceuticals include Eledon Pharmaceuticals (ELDN), Pyxis Oncology (PYXS), NeOnc Technologies Holdings, Inc. Common Stock (NTHI), OUTLOOK THERAPEUTICS INC (OTLK) and Vanda Pharmaceuticals (VNDA), listed from the closest match.

    Who is Oramed Pharmaceuticals' biggest competitor?

    Rocket Pharmaceuticals (RCKT) is the largest of the similar companies at $256.82M; Eledon Pharmaceuticals (ELDN) is the closest match by business profile, size, sector and industry.

    How does ORMP stock compare with its competitors?

    ORMP's net margin is 0.0% against a peer median of 0.0%.

    Which of Oramed Pharmaceuticals' competitors pays a higher dividend?

    Oramed Pharmaceuticals has a forward dividend yield of 6.41%. None of the similar companies with available yields has a higher forward dividend yield.

    Is Oramed Pharmaceuticals bigger than its competitors?

    No. Oramed Pharmaceuticals is 8th by market cap among the 13 companies on this page; the largest is Rocket Pharmaceuticals (RCKT) at $256.82M.